Search Tag: vaccine
2022 21 Oct
Global experts continue to join SK bioscience, while its U.S. corporate entity is being established Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across...Read more
2022 11 Jan
Pfizer Inc Chief Executive Albert Bourla said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March. Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both...Read more
2021 15 Feb
Since the start of the COVID-19 pandemic, digitalisation in healthcare has become as important as probably never before. Its upgraded role spans across a multitude of areas, from blockchain applications and smart hospitals to patient data protection and vaccine logistics. An expert provides an overview of the most promising trends and technologies...Read more
2021 15 Feb
A recent paper (Vander Stichele et al. 2020) published in Vaccine highlighted the need for global monitoring of vaccine use (who was inoculated with which vaccine product, where and when) as well as its safety and effectiveness. HealthManagement.org asked the authors about the challenges of implementing such system in practice and possible measures...Read more
2020 30 Nov
Key Points For the past 10 months, COVID-19 has spread rapidly, debilitating communities, plummeting economies, and killing 1.3 million people worldwide. According to the CDC, pregnant women are at higher risk for severe COVID-19 outcomes compared with non-pregnant women. Immunisations are especially important in pregnancy, to ensure...Read more
2020 11 Nov
According to the latest reports, the COVID-19 vaccine developed by Pfizer and BioNTech has been tested on 43,500 people in six countries and shows 90% protection within seven days after the second dose. The vaccine, which has been tested in participants in the U.S., Germany, Brazil, Argentina, South Africa and Turkey, could be a real game-changer in...Read more
2020 02 Oct
The world is desperate for a reliable vaccine against COVID-19. However, the pressure for such rapid introduction could lead to deployment of a vaccine that may be weakly effective. In order to avoid this from happening, three issues must be considered when planning COVID-19 vaccine trials. These include proof of vaccine efficacy and worthwhile...Read more
2020 19 May
Prof. Maurizio Cecconi is the President-Elect of the European Society of Intensive Care Medicine (ESICM). He is also the Head of Anaesthesia and Intensive Care Department at Istituto Clinico Humanitas and a full professor of Anaesthesia and ICU at the Humanitas University. Prof. Cecconi has worked in different healthcare systems, including the...Read more
2020 21 Apr
The battle against the COVID-19 contagion highlights the heroic efforts of healthcare professionals and other frontline workers. As these heroes bravely perform their duties, those of us sheltered at home can do our share in helping find a cure to this infectious disease. You might also like: Witty to Help WHO with COVID-19 Vaccine Development...Read more
2015 23 Feb
Scientists from The Scripps Research Institute (TSRI) have announced the creation of a novel drug candidate that is so potent and universally effective that it could possibly work as part of an unconventional vaccine. The remarkable research involved scientists from more than a dozen research institutions and has been published in the journal...Read more
2014 23 Oct
A new study published in Vaccine reveals for the first time the molecular mechanism which helps to explain how flu vaccines may be able to prevent heart attacks. Flu vaccines have long been known to have a protective effect against heart disease, thus reducing the risk of a heart attack. However, there is not much scientific information to explain...Read more
2014 10 Sep
Emerging technologies are helping pharmaceutical companies to develop needle-free vaccines that are more efficient to use compared to vaccines that are delivered via traditional methods (i.e., needles and syringes). Drug delivery technologies that improve access and overall efficacy have become an essential part of the entire drug development process,...Read more
2014 05 Aug
A recent research published in Infection and Immunity talks about an experimental vaccine that was able to protect 100% of animal models against Clostridium difficile, a highly infectious and virulent bacterium. This bacterium causes an intestinal disease that kills nearly 30,000 Americans annually. C-difficile associated disease (CDAD) is caused...Read more
2014 11 Mar
Together with researchers from around the UK, a team of oncologists from The Clatterbridge Cancer Centre has been conducting a project to develop a ground-breaking cancer vaccine that can be utilised alongside traditional treatment methods in order to fight pancreatic cancer. Pancreatic cancer is the fifth biggest cause of cancer related deaths,...Read more
2014 24 Feb
A recent study conducted by a team of academics from the UK’s University of Lincoln and The University of Nottingham, and published in the scientific journal Vaccine, has found that patients who had been vaccinated against influenza were 24% less likely to suffer a stroke in the same flu season. During previous research in 2010 the same team...Read more
2014 09 Jan
Astellas Pharma Inc. and ClearPath Development Company announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases. The partnership was established to support Astellas’ goal of building a global vaccine franchise and launched its first company, RSV Corporation (RSVC), in...Read more
2013 28 Nov
December 1st is annual World AIDS Day, presenting an ideal opportunity to view the progress made by medical research in fighting the disease. There are 35 million people infected by HIV worldwide, hence the disease is still most prevalent. Despite the fact that antiretroviral drugs manage to slow down the progression of the condition, they come...Read more